Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Some clinical trials have asked participants to pay $7,000 or so to enroll. Another wanted to ask for upward of $250,000.
Michele Russell-Einhorn has spent 23 years working in the world of institutional review boards, which decide whether to green-light clinical trials. In all that time, she’s never seen quite so many proposals as she has in the past year that rely on an unusual — and controversial — funding mechanism.
Some plan to ask participants to pay $7,000 or so to enroll. Another wanted to ask for upward of $250,000.
In each case, there were “serious concerns about how ethical it was to charge people to participate in the research — and whether it was absolutely necessary,” said Russell-Einhorn, chief compliance officer for Advarra, the
